Conduit Pharmaceuticals Inc.

NASDAQ
CDT
Stock
Yield per half year: -97.69%
Dividend yield: 0%
Sector: Healthcare

Share chart Conduit Pharmaceuticals Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Main settings

IPO date 2023-09-25
ISIN US20678X1063
Industry Life Sciences Tools & Services
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт link
Цена ао 3.48
Change price per day: 0% (3.69)
Change price per week: -10.22% (4.11)
Change price per month: -56.07% (8.4)
Change price per 3 month: -78.04% (16.8)
Change price per half year: -97.69% (160.05)
Change price per year: +23% (3)
Change price per 3 year: -62.99% (9.97)
Change price per year to date: -96.77% (114.15)
All parameters

Grade

Underestimation
Title Value Grade
P/S 1.92 7
P/BV 3.64 5
P/E 23.76 6
EV/EBITDA 20.92 5
Total: 6.38
Efficiency
Title Value Grade
ROA, % 12.13 4
ROE, % 30.66 9
Total: 3.33
Dividends
Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0.0986
Debt
Title Value Grade
Debt/EBITDA 4.62 1
Total: 4.4
Growth impulse
Title Value Grade
Yield Revenue, % 0 3
Yield Ebitda, % -9968.89 0
Yield EPS, % -9690.4 0
Total: 0.6
More

Main owners

Institutions Volume Share, %
Bank of Montreal/Can/ 10 000 0.01
Kepos Capital LP 1 500 0
Wells Fargo & Company 72 0
Morgan Stanley 25 0

Similar companies

P/E & P/BVEV/Ebitda & Debt/Ebitda


Company management

Head Job title Payment Year of birth
Dr. David Joszef Tapolczay CEO & Director 419.8k 1959 (66 years)
Dr. Joanne M. Holland Chief Scientific Officer N/A 1975 (50 years)
Mr. James Bligh Interim CFO & Director 1988 (37 years)
Mr. Bill Begien Senior VP of Investor Relations

About company

Address: United States, San Diego. CA, 4995 Murphy Canyon Road - Open in google maps, Open in yandex maps
Website: https://www.conduitpharma.com